TRT / RTR Design [RSABE / ABEL]

posted by mittyri – Russia, 2017-05-02 20:38 (2550 d 02:34 ago) – Posting: # 17295
Views: 8,842

Dear Yura,

you should use all data included in PK analysis (ie all subjects) for CI estimation.
To extent the limits you need to calculate variability of RR, that is, 50% of subjects.
A hint: even if you try to calculate variability of RR for overall dataset, the majority of software (at least SAS PHX, R) is smart enough not to include the subjects with one R.

❝ The appropriate sample size must be.

❝ Alpha correction.

what did you mean here?

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,651 registered users;
116 visitors (0 registered, 116 guests [including 6 identified bots]).
Forum time: 23:13 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5